IntraBio Ltd., which is a subsidiary of IntraBio Inc, is a private pharmaceutical company located in Oxford, United Kingdom, focusing on the development and commercialization of novel and repurposed drugs to treat common and rare neurodegenerative diseases, including lysosomal storage disorders.